Alfuzosin

Pediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Adrenergic neurone blockers, Alcohol, Aldesleukin, Alprostadil, Amitriptyline, Angiotensin II receptor antagonists, Antipsychotics, Anxiolytics and hypnotics, Arsenic, Atazanavir, Atenolol, Baclofen, Beta blockers, Boceprevir, Calcium channel blockers, Cimetidine, Citalopram, Clonidine, Conivaptan, Corticosteroids, CYP3A4 inducers or inhibitors, Darunavir, Dasatinib, Deferasirox, Degarelix, Delavirdine, Diazoxide, Diltiazem, Diuretics, Estrogens, Food, General anesthetics, Hydralazine, Indinavir, Itraconazole, Ketoconazole, Lapatinib, Levodopa, Levofloxacin, Lopinavir, MAO inhibitors, Methyldopa, Minoxidil, Moxifloxacin, Moxisylyte, Moxonidine, Nelfinavir, Nitrates, Nitroprusside, NSAIDs, Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir, Pazopanib, Phosphodiesterase 5 inhibitors, Protease inhibitors, QT prolonging agents, Ritonavir, Sildenafil, St John's Wort, Tadalafil, Telaprevir, Telavancin, Telithromycin, Tipranavir, Tizanidine, Vardenafil, Voriconazole, Vorinostat, Ziprasidone

PREGNANCY CATEGORY: B

Our database has 30 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 08/02/2021

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top